Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif., August 25, 2025—-Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), […]
LIVERMORE, Calif., Aug. 27, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pleased to announce that it has engaged Fata Advisory, LLC to support the […]
TAMPA, FL / August 27, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics Health” or the “Company”), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the introduction of HubRx AI – a fully […]
LIVERMORE, Calif., Aug. 26, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pursuing new initiatives in the space sector with the European Space Agency (ESA) […]
LIVERMORE, Calif., Aug. 21, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation driven leader in the fuel cell and hydrogen technology space, has entered into an agreement with a U.S. based global leader […]
LIVERMORE, Calif., Aug. 18, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is supplying its proprietary membrane electrode assembly technology to Stralis Aircraft, based […]
LIVERMORE, Calif., Aug. 12, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement […]
Planned IPO Aligns with Aditxt’s Acquire, Build and Capitalize (ABC) Monetization Framework MOUNTAIN VIEW, Calif., July 29, 2025—-Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, […]
The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma […]
Next Super Stock Aditxt (NASDAQ: ADTX) Next Super Stock: Aditxt (NASDAQ: ADTX) is a “Unicorn Farm” – buying, building – then monetizing innovative healthcare assets with billion dollar market opportunities. $ADTX is a classic TEN […]
Winnipeg, Manitoba— July 22, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, provides an update on its equity investment strategy regarding North American, […]
NEW YORK, July 22, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced a CRADA (Cooperative Research and Development Agreement) with the U.S. Department of Veterans Affairs and Foundation for Atlanta Veterans […]
Winnipeg, Manitoba– – July 18, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, provides an update on progress at its uranium projects in […]
Plan Combines Bitcoin Treasury Strategy and Equity Line to Support 2026 Potential Monetization Events, Starting with Pearsanta’s Planned IPO MOUNTAIN VIEW, Calif.—Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health […]
Hoth Therapeutics’ HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key Opinion Leader (KOL) event on, at 3:30PM EST to […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
